Scientia Vascular, a West Valley City neurovascular medical devices provider, has announced that Rick Randall will replace founder John Lippert as CEO of the company. Lippert will transition to chief technology officer, focusing on advancing next-generation patient solutions and therapies.
Randall has over 35 years in the medical device industry leading neuro-focused organizations, including guiding companies through public offerings and overseeing mergers and acquisitions. His background encompasses strategic planning, product marketing and commercialization of minimally invasive therapeutic products. He served as CEO of Target Therapeutics, where he was pivotal in bringing the neuro-interventional company public and developing pioneering technologies.
“Rick’s leadership will be instrumental in expanding our Please log in to see the rest of this story.
